Nalaganje...
Dawn of Theranostics in Myanmar (Dream, Reality, and Constraint)
Prostate cancer is third common malignancy in men of old age (average 65 years) in Myanmar. Currently, serum PSA and bone scan are the markers of choice. Because of the evidence-based, promising success of (68)Ga-PSMA PET-CT and (177)Lu-PSMA theranostics in prostate cancer worldwide, (99m)Tc-PSMA SP...
Shranjeno v:
| izdano v: | Nucl Med Mol Imaging |
|---|---|
| Main Authors: | , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Springer Berlin Heidelberg
2019
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6377584/ https://ncbi.nlm.nih.gov/pubmed/30828400 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13139-018-00569-4 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|